相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficient Presentation of Soluble Antigen by Cultured Human Dendritic Cells Is Maintained by Granulocyte/Macrophage Colony-stimulating Factor Plus Interleukin 4 and Downregulated by Tumor Necrosis Factor α
Federica Sallusto et al.
JOURNAL OF IMMUNOLOGY (2018)
Dendritic cell vaccines in acute leukaemia
Caroline Duncan et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2008)
Development of a dendritic cell-based vaccine for chronic lymphocytic leukemia
M. Palma et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration
A. C. Inge Boullart et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Dendritic cell vaccination and immune monitoring
E. H. J. G. Aarntzen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies
Lionel Apetoh et al.
CANCER RESEARCH (2008)
Survivin: Key regulator of mitosis and apoptosis and novel target for cancer therapeutics
Alain C. Mita et al.
CLINICAL CANCER RESEARCH (2008)
Immune cells in colorectal cancer: prognostic relevance and therapeutic strategies
Imke Atreya et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2008)
Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines
Joseph D. Miller et al.
IMMUNITY (2008)
Combined use of toll-like receptor agonists and prostaglandin E2 in the FastDC model:: Rapid generation of human monocyte-derived dendritic cells capable of migration and IL-12p70 production
Marc Dauer et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
Interferon-alpha (IFN-α)-conditioned DC preferentially stimulate type-1 and limit Treg-type in vitro T-cell responses from RCC patients
Margherita Gigante et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Type 1-polarized dendritic cells loaded with autologous tumor are a potent immunogen against chronic lymphocytic leukemia
Je-Jung Lee et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Natural killer cell-directed therapies: moving from unexpected results to successful strategies
Magali Terme et al.
NATURE IMMUNOLOGY (2008)
Treatment of metastatic melanoma with autologous CD4+T cells against NY-ESO-1
Naomi N. Hunder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Dendritic Cell Immunotherapy for Malignant Gliomas
Anne Luptrawan et al.
REVIEWS ON RECENT CLINICAL TRIALS (2008)
Taming cancer by inducing immunity via dendritic cells
A. Karolina Palucka et al.
IMMUNOLOGICAL REVIEWS (2007)
IDO expands human CD4+CD25high regulatory T cells by promoting maturation of LPS-treated dendritic cells
Marcelo Hill et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis
M. Obeid et al.
CELL DEATH AND DIFFERENTIATION (2007)
A HLA-DQ5 restricted Melan-A/MART-1 epitope presented by melanoma tumor cells to CD4+T lymphocytes
Pierre Larrieu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Cancer immunotherapy by exosome-based vaccines
Siguo Hao et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2007)
Effective clinical-scale production of dendritic cell vaccines by monocyte elutriation directly in medium, subsequent culture in bags and final antigen loading using peptides or RNA transfection
Michael Erdmann et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Immunotherapy with dendritic cells for prostate cancer
Anna-Katharina Thomas-Kaskel et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer
Kunle Odunsi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Dendritic cell vaccine strategies for renal cell carcinoma
Dolores J. Schendel
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
Chemokine-guided CD4+ T cell help enhances generation of IL-6RαhighIL-7Rαhigh prememory CD8+ T cells
Flora Castellino et al.
JOURNAL OF IMMUNOLOGY (2007)
Calreticulin exposure dictates the immunogenicity of cancer cell death
Michel Obeid et al.
NATURE MEDICINE (2007)
Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells
Jon A. Kyte et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients
Jan Wierecky et al.
CANCER RESEARCH (2006)
Culture medium and protein supplementation in the generation and maturation of dendritic cells
P. -J. Royer et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2006)
The interactions of dendritic cells with antigen-specitic, regulatory T cells that suppress autoimmunity
KV Tarbell et al.
SEMINARS IN IMMUNOLOGY (2006)
Prostaglandin E2 is generally required for human dendritic cell migration and exerts its effect via EP2 and EP4 receptors
DF Legler et al.
JOURNAL OF IMMUNOLOGY (2006)
Dendritic cell derived-exosomes: biology and clinical implementations
Nathalie Chaput et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Dendritic cell immunotherapy for breast cancer
Alberto Pinzon-Charry et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2006)
Th1-polarizing capacity of clinical-grade dendritic cells is triggered by ribomunyl but is compromised by PGE2 -: The importance of maturation cocktails
W Jongmans et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia
I Hus et al.
LEUKEMIA (2005)
Biodistribution of radiolabelled human dendritic cells injected by various routes
V Quillien et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro-transcribed MUC1 RNA
D Dörfel et al.
BLOOD (2005)
Dendritic-cell-based therapeutic vaccination against cancer
FO Nestle et al.
CURRENT OPINION IN IMMUNOLOGY (2005)
Dendritic cells as therapeutic vaccines against cancer
J Banchereau et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Dendritic cell-mediated T cell polarization
EC de Jong et al.
SPRINGER SEMINARS IN IMMUNOPATHOLOGY (2005)
Dendritic cell immunotherapy: mapping the way
CG Figdor et al.
NATURE MEDICINE (2004)
The Tubingen approach: identification, selection, and validation of tumor-associated HLA peptides for cancer therapy
H Singh-Jasuja et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Toll-like receptors and dendritic cells: for whom the bug tolls
CRE Sousa
SEMINARS IN IMMUNOLOGY (2004)
Induction of adipophilin-specific cytotoxic T lymphocytes using a novel HLA-A2-binding peptide that mediates tumor cell lysis
SM Schmidt et al.
CANCER RESEARCH (2004)
Proteasome and peptidase function in MHC-class-I-mediated antigen presentation
PM Kloetzel et al.
CURRENT OPINION IN IMMUNOLOGY (2004)
Increased expression of inducible HSP70 in apoptotic cells is correlated with their efficacy for antitumor vaccine therapy
D Massé et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Mature human Langerhans cells derived from CD3+ hematopoietic progenitors stimulate greater cytolytic T lymphocyte activity in the absence of bioactive IL-12p70, by either single peptide presentation or cross-priming, than do dermal-interstitial or monocyte-derived dendritic cells
G Ratzinger et al.
JOURNAL OF IMMUNOLOGY (2004)
Sequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicity
MF Kalady et al.
JOURNAL OF SURGICAL RESEARCH (2004)
Expansion of melanoma-specific cytolytic CD8+ T cell precursors in patients with metastatic melanoma vaccinated with CD34+ progenitor-derived dendritic cells
S Paczesny et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Danger signals: a time and space continuum
M Skoberne et al.
TRENDS IN MOLECULAR MEDICINE (2004)
The heat-shock protein receptors: some answers and more questions
RJ Binder et al.
TISSUE ANTIGENS (2004)
Cutting edge:: CD4+ T cell help can be essential for primary CD8+ T cell responses in vivo
JCE Wang et al.
JOURNAL OF IMMUNOLOGY (2003)
Optimizing dendritic cell-based anticancer immunotherapy: maturation state does have clinical impact
D McIlroy et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2003)
ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells
P Guermonprez et al.
NATURE (2003)
Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells
SM Schmidt et al.
BLOOD (2003)
The diversity of immunological synapses
A Trautmann et al.
CURRENT OPINION IN IMMUNOLOGY (2003)
Delivery of tumor-derived RNA for the induction of cytotoxic T-lymphocytes
F Grünebach et al.
GENE THERAPY (2003)
Anti-cancer therapy using dendritic cells and apoptotic tumour cells:: pre-clinical data in human mesothelioma and acute myeloid leukaemia
M Grégoire et al.
VACCINE (2003)
Making sense of mass destruction: Quantitating MHC class I antigen presentation
JW Yewdell et al.
NATURE REVIEWS IMMUNOLOGY (2003)
Leukemic dendritic cells: potential for therapy and insights towards immune escape by leukemic blasts
M Mohty et al.
LEUKEMIA (2002)
Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patients
N Labarrière et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Randomized trial of adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma
B Dréno et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
Large-scale generation of mature monocyte-derived dendritic cells for clinical application in cell factories™
TG Berger et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived denctritic cells
E Scandella et al.
BLOOD (2002)
The immunological synapse
RJ Creusot et al.
MOLECULAR IMMUNOLOGY (2002)
Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients
JM Timmerman et al.
BLOOD (2002)
Identification of a clinical-grade maturation factor for dendritic cells
C Boccaccio et al.
JOURNAL OF IMMUNOTHERAPY (2002)
Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4+ T cells
J Geginat et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells
ML Albert et al.
NATURE IMMUNOLOGY (2001)
Dendritic cells as vectors for therapy
J Banchereau et al.
CELL (2001)
Regulation of T cell immunity by dendritic cells
A Lanzavecchia et al.
CELL (2001)
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy
L Fong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection
H Jonuleit et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Progress in human tumour immunology and immunotherapy
SA Rosenberg
NATURE (2001)
Dendritic cells injected via different routes induce immunity in cancer patients
L Fong et al.
JOURNAL OF IMMUNOLOGY (2001)
Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells
MV Dhodapkar et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Kinetics of dendritic cell activation:: impact on priming of TH1, TH2 and nonpolarized T cells
A Langenkamp et al.
NATURE IMMUNOLOGY (2000)
Autologous, allogeneic tumor cells or genetically engineered cells as cancer vaccine against melanoma
D Schadendorf et al.
IMMUNOLOGY LETTERS (2000)
Mature dendritic cells boost functionally superior CD8+ T-cell without foreign helper epitopes
MV Dhodapkar et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells
B Sauter et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
